Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial

WHO Handbook for Reporting Results of Cancer Treatment

1982 • 2,214 citations

A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer.

1989 • 467 citations

An overview of prognostic factors in small cell lung cancer

1990 • 206 citations

Cancer and its Management

2009 • 148 citations

Bioavailability of low-dose oral etoposide.

1993 • 147 citations

Introducing new treatments for cancer : practical, ethical and legal problems

1992 • 131 citations

Schedule dependency of 21-day oral versus 3-day intravenous etoposide in combination with intravenous cisplatin in extensive-stage small-cell lung cancer: a randomized phase III study of the Cancer and Leukemia Group B.

1995 • 106 citations

Radiotherapy alone or with chemotherapy in the treatment of small-cell carcinoma of the lung.

1979 • 72 citations

Variable bioavailability following repeated oral doses of etoposide

1985 • 65 citations

Current status of therapy for small cell carcinoma of the lung

1984 • 63 citations

Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis

1996 • 54 citations

The activity of 10-, 14-, and 21-day schedules of single-agent etoposide in previously untreated patients with extensive small cell lung cancer.

1992 • 51 citations

Treatment-related deaths in small cell lung cancer trials: can patients at risk be identified?

1994 • 38 citations

Cancer and Its Management

1987 • 21 citations

A prospective study of low dose oral etoposide in poor prognosis small cell lung cancer (SCLC)

1991 • 5 citations